Cargando…

Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma

In the last years, the life expectancy of multiple myeloma (MM) patients has substantially improved thanks to the availability of many new drugs. Our ability to induce deep responses has improved as well, and the treatment goal in patients tolerating treatment moved from the delay of progression to...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliva, Stefania, D'Agostino, Mattia, Boccadoro, Mario, Larocca, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006453/
https://www.ncbi.nlm.nih.gov/pubmed/32076595
http://dx.doi.org/10.3389/fonc.2020.00001